SA
QNDPF logo
Qingdao Port International Co., Ltd.(QNDPF)
Closing price · checked 11:04 PM ETAbout this dataData status
$0.87▲0.00 (0.00%)
Extended:$0.87+0.00 (+0.00%)· 11:04 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Qingdao Port International Co., Ltd. (QNDPF)

R&D to Revenue

0.60%

Fiscal year · Period ending:

QNDPF logo

QNDPF R&D to Revenue

Latest reported0.60%
QNDPF FY R&D/Revenue (0.19% → 0.60%)
Powered by
High-resolution chart · PNG

What is r&d to revenue?

R&D spending as percentage of revenue.

QNDPF r&d to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

Qingdao Port International Co., Ltd. R&D to Revenue — Annual fiscal periods
Period endingR&D to RevenueChange
0.5973%+0.04 pts
0.5543%−0.02 pts
0.5774%−0.00 pts
0.5776%+0.08 pts
0.4932%+0.34 pts
0.1526%−0.12 pts
0.2776%−0.06 pts
0.3384%+0.14 pts
0.1942%+0.19 pts
0%0.00 pts
0%0.00 pts
0%0.00 pts
0%−0.19 pts
0.1916%—

Frequently asked questions: QNDPF r&d to revenue

What is Qingdao Port International Co., Ltd. (QNDPF)'s current r&d to revenue?

Qingdao Port International Co., Ltd. (QNDPF)'s latest reported r&d to revenue (Fiscal year) is 0.60% as of Dec 31, 2025. R&D spending as percentage of revenue.

How much historical r&d to revenue data is available for QNDPF?

Stock Alarm Pro provides 14 dated annual fiscal periods observations for Qingdao Port International Co., Ltd. (QNDPF)'s r&d to revenue, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare QNDPF's r&d to revenue to peers or set an alert?

You can open QNDPF's r&d to revenue in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on QNDPF delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.